Philip Morris International is a leading global organization in the tobacco industry, primarily known for manufacturing and distributing a variety of smokeable products, including cigarettes and heated tobacco devices. The company is committed to transforming its business by investing in reduced-risk products, promoting alternatives to traditional smoking, such as e-cigarettes and heated tobacco products that aim to deliver nicotine without the harmful effects associated with combustion. With a strong emphasis on innovation and sustainability, Philip Morris International is actively shifting its focus towards a smoke-free future, striving to create a healthier environment while still engaging its customer base. Read More
Join us as we dissect Philip Morris International's stock performance and explore whether it can thrive in a changing market landscape. Will it be a solid investment or a risky bet?
Philip Morris asked the FDA to allow reduced-risk claims for ZYN, citing advisory-panel-reviewed evidence that switching from cigarettes lowers several disease risks.
Experts from Philip Morris International (PMI) (NYSE: PM) yesterday presented scientific evidence to the U.S. Food and Drug Administration’s (FDA) Tobacco Products Scientific Advisory Committee (TPSAC) as part of the FDA’s process for a Modified Risk Tobacco Product (MRTP) designation for their ZYN nicotine pouch products. This designation would allow PMI’s U.S. family of businesses to communicate to U.S. legal-aged, 21+ adult cigarette smokers that switching completely to ZYN reduces their risk of many smoking-related diseases and we look forward to a decision by FDA.
Philip Morris International Inc. (NYSE: PM) today released a new white paper, “Human Cognition: The Next Frontier?”, inviting leaders across business, policy, and academia to join a global conversation on the evolving role of human cognition as artificial intelligence transforms work, society, and the economy.
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Philip Morris International (NYSE: PM) and its U.S. businesses (PMI U.S.) are strongly committed to investing in America, with over $20 billion of PMI investments since 2022 majority-related to both acquiring and further investing in U.S. manufacturing capabilities, commercial rights and infrastructure, and U.S. jobs.
Philip Morris is expected to report its fourth-quarter earnings shortly, and analysts are projecting low-single-digit growth in profits, reflecting steady operating performance.
Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. On the other hand, they usually underperform during bull runs,
and this paradigm has rung true over the past six months as the sector’s -9.1% decline paled in comparison to the S&P 500’s 11.7% gain.
As of December 15, 2025, Altria Group, Inc. (NYSE: MO) stands as a titan in the U.S. consumer staples sector, primarily known for its vast portfolio of tobacco products. The company is at a pivotal juncture, navigating a market characterized by declining traditional cigarette consumption and a rapid shift towards smoke-free alternatives. Altria's current relevance [...]
